{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:51:26Z","timestamp":1793641886262,"version":"4.5.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T00:00:00Z","timestamp":1649462400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T00:00:00Z","timestamp":1649462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s43440-022-00364-1","type":"journal-article","created":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T02:02:35Z","timestamp":1649469755000},"page":"481-492","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Salubrious effects of ulinastatin and quercetin alone or in combination in endothelial dysfunction and vascular dementia"],"prefix":"10.1007","volume":"74","author":[{"given":"Poonam","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikita","family":"Gaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalini","family":"Jayant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. M.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhagwat","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harsha","family":"Kharkwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3423-007X","authenticated-orcid":false,"given":"Bhupesh","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,9]]},"reference":[{"key":"364_CR1","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1016\/S0140-6736(15)00463-8","volume":"386","author":"JT O\u2019Brien","year":"2015","unstructured":"O\u2019Brien JT, Thomas A. Vascular dementia. The Lancet. 2015;386:1698\u2013706.","journal-title":"The Lancet"},{"issue":"5","key":"364_CR2","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1080\/01616412.1997.11740844","volume":"19","author":"CG Lis","year":"1997","unstructured":"Lis CG, Gaviria M. Vascular dementia, hypertension, and the brain. Neurol Res. 1997;19(5):471\u201380.","journal-title":"Neurol Res"},{"issue":"1","key":"364_CR3","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.pbb.2012.03.029","volume":"102","author":"B Sharma","year":"2012","unstructured":"Sharma B, Singh N. Experimental hypertension induced vascular dementia: pharmacological biochemical and behavioral recuperation by angiotensin receptor blocker and acetylcholinesterase inhibitor. Pharmacol Biochem Behav. 2012;102(1):101\u20138.","journal-title":"Pharmacol Biochem Behav"},{"issue":"4","key":"364_CR4","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.neuron.2013.10.008","volume":"80","author":"C Iadecola","year":"2013","unstructured":"Iadecola C. The pathobiology of vascular dementia. Neuron. 2013;80(4):844\u201366.","journal-title":"Neuron"},{"issue":"5","key":"364_CR5","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1161\/HYPERTENSIONAHA.113.01063","volume":"62","author":"G Faraco","year":"2013","unstructured":"Faraco G, Iadecola C. Hypertension: a harbinger of stroke and dementia. Hypertension. 2013;62(5):810\u20137.","journal-title":"Hypertension"},{"key":"364_CR6","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.physbeh.2015.02.009","volume":"142","author":"P Singh","year":"2015","unstructured":"Singh P, Gupta S, Sharma B. Melatonin receptor and KATP channel modulation in experimental vascular dementia. Physiol Behav. 2015;142:66\u201378.","journal-title":"Physiol Behav"},{"issue":"1","key":"364_CR7","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3892\/br.2012.26","volume":"1","author":"S Zhang","year":"2013","unstructured":"Zhang S, Li H, Li Y, Zhang F, Liu Y, Chen X. Nicousamide normalizes renovascular hypertension in two-kidney one-clip hypertensive rats. Biomed Rep. 2013;1(1):89\u201392.","journal-title":"Biomed Rep"},{"issue":"4","key":"364_CR8","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1161\/01.HYP.29.4.1025","volume":"29","author":"P Wiesel","year":"1997","unstructured":"Wiesel P, Mazzolai L, Nussberger J, Pedrazzini T. Two-kidney, one clip and one-kidney, one clip hypertension in mice. Hypertension. 1997;29(4):1025\u201330.","journal-title":"Hypertension"},{"key":"364_CR9","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1097\/00004647-200005000-00001","volume":"5","author":"D Vivien","year":"2000","unstructured":"Vivien D, Buisson A. Serine protease inhibitors: novel therapeutic targets for stroke? J Cereb Blood Flow Metab. 2000;5:755\u201364.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"9","key":"364_CR10","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S0166-2236(00)01617-9","volume":"23","author":"MB Gingrich","year":"2000","unstructured":"Gingrich MB, Traynelis SF. Serine proteases and brain damage\u2014is there a link? Trends Neurosci. 2000;23(9):399\u2013407.","journal-title":"Trends Neurosci"},{"issue":"1","key":"364_CR11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1055\/s-2006-939553","volume":"32","author":"NW Bunnett","year":"2006","unstructured":"Bunnett NW. Protease-activated receptors: how proteases signal to cells to cause inflammation and pain. Semin Thromb Hemost. 2006;32(1):39\u201348.","journal-title":"Semin Thromb Hemost"},{"key":"364_CR12","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.biopha.2016.11.044","volume":"85","author":"M Liu","year":"2017","unstructured":"Liu M, Shen J, Zou F, Zhao Y, Li B, Fan M. Effect of ulinastatin on the permeability of the blood\u2013brain barrier on rats with global cerebral ischemia\/reperfusion injury as assessed by MRI. Biomed Pharmacother. 2017;85:412\u20137.","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"364_CR13","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3109\/00207454.2015.1025394","volume":"126","author":"L Ma","year":"2016","unstructured":"Ma L, Zhang H, Liu YZ, Yin YL, Ma YQ, Zhang SS. Ulinastatin decreases permeability of blood\u2013brain barrier by inhibiting expression of MMP-9 and t-PA in postoperative aged rats. Int J Neurosci. 2016;126(5):463\u20138.","journal-title":"Int J Neurosci"},{"issue":"2","key":"364_CR14","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s12013-014-0239-3","volume":"71","author":"T Cui","year":"2015","unstructured":"Cui T, Zhu G. Ulinastatin attenuates brain edema after traumatic brain injury in rats. Cell Biochem Biophys. 2015;71(2):595\u2013600.","journal-title":"Cell Biochem Biophys"},{"key":"364_CR15","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.expneurol.2017.12.016","volume":"302","author":"XF Li","year":"2018","unstructured":"Li XF, Zhang XJ, Zhang C, Wang LN, Li YR, Zhang Y, et al. Ulinastatin protects brain against cerebral ischemia\/reperfusion injury through inhibiting MMP-9 and alleviating loss of ZO-1 and occludin proteins in mice. Exp Neurol. 2018;302:68\u201374.","journal-title":"Exp Neurol"},{"issue":"10","key":"364_CR16","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1080\/01616412.2019.1642564","volume":"41","author":"M Guo","year":"2019","unstructured":"Guo M, Zhu X, Xu H, Li J, Yang S, Zuo Z, et al. Ulinastatin attenuates isoflurane-induced cognitive dysfunction in aged rats by inhibiting neuroinflammation and \u03b2-amyloid peptide expression in the brain. Neurol Res. 2019;41(10):923\u20139.","journal-title":"Neurol Res"},{"issue":"8","key":"364_CR17","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/0006-3223(96)00262-4","volume":"40","author":"T Inagaki","year":"1996","unstructured":"Inagaki T, Shikimi T, Fujimoto A, Ishino H, Okunishi H, Takaori S. Changes in the ratio of urinary alpha 1-microglobulin to ulinastatin levels in patients with psychiatric diseases. Biol Psychiatry. 1996;40(8):800\u20133.","journal-title":"Biol Psychiatry"},{"issue":"6","key":"364_CR18","first-page":"435","volume":"54","author":"LJ Cao","year":"2011","unstructured":"Cao LJ, Wang J, Hao PP, Sun CL, Chen YG. Effects of ulinastatin, a urinary trypsin inhibitor, on synaptic plasticity and spatial memory in a rat model of cerebral ischemia\/reperfusion injury. Chin J Physiol. 2011;54(6):435\u201342.","journal-title":"Chin J Physiol"},{"key":"364_CR19","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.3389\/fphar.2018.01007","volume":"9","author":"M Zhang","year":"2018","unstructured":"Zhang M, Zhang YH, Fu HQ, Zhang QM, Wang TL. Ulinastatin may significantly improve postoperative cognitive function of elderly patients undergoing spinal surgery by reducing the translocation of lipopolysaccharide and systemic inflammation. Front Pharmacol. 2018;9:1007.","journal-title":"Front Pharmacol"},{"issue":"9","key":"364_CR20","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1179\/016164110X12645013515133","volume":"32","author":"Y Koga","year":"2010","unstructured":"Koga Y, Fujita M, Tsuruta R, Koda Y, Nakahara T, Yagi T, et al. Urinary trypsin inhibitor suppresses excessive superoxide anion radical generation in blood, oxidative stress, early inflammation, and endothelial injury in forebrain ischemia\/reperfusion rats. Neurol Res. 2010;32(9):925\u201332.","journal-title":"Neurol Res"},{"issue":"9","key":"364_CR21","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.6061\/clinics\/2013(09)10","volume":"68","author":"CL Hu","year":"2013","unstructured":"Hu CL, Xia JM, Cai J, Li X, Liao XX, Li H, et al. Ulinastatin Attenuates oxidation, inflammation and neural apoptosis in the cerebral cortex of adult rats with ventricular fibrillation after cardiopulmonary resuscitation. Clinics (Sao Paulo). 2013;68(9):1231\u20138.","journal-title":"Clinics (Sao Paulo)"},{"issue":"11","key":"364_CR22","first-page":"7094","volume":"11","author":"X Xie","year":"2019","unstructured":"Xie X, Li T, Yuan H. Protective effects of ulinastatin on oxidative stress and inflammation of rat-derived cardiomyocytes H9c2. Am J Transl Res. 2019;11(11):7094\u2013103.","journal-title":"Am J Transl Res"},{"issue":"1","key":"364_CR23","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.bbr.2010.01.017","volume":"209","author":"S Tota","year":"2010","unstructured":"Tota S, Awasthi H, Kamat PK, Nath C, Hanif K. Protective effect of quercetin against intracerebral streptozotocin induced reduction in cerebral blood flow and impairment of memory in mice. Behav Brain Res. 2010;209(1):73\u20139.","journal-title":"Behav Brain Res"},{"issue":"3","key":"364_CR24","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1042\/bj3580547","volume":"358","author":"H Schroeter","year":"2001","unstructured":"Schroeter H, Spencer JP, Rice-Evans C, Williams RJ. Flavonoids protect neurons from oxidized low-density-lipoprotein-induced apoptosis involving c-Jun N-terminal kinase (JNK), c-Jun and caspase-3. Biochem J. 2001;358(3):547\u201357.","journal-title":"Biochem J"},{"key":"364_CR25","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s12263-007-0056-z","volume":"2","author":"JP Spencer","year":"2007","unstructured":"Spencer JP. The interactions of flavonoids within neuronal signalling pathways. Genes Nutr. 2007;2:257\u201373.","journal-title":"Genes Nutr"},{"issue":"4","key":"364_CR26","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s12263-009-0136-3","volume":"4","author":"JP Spencer","year":"2009","unstructured":"Spencer JP. Flavonoids and brain health: multiple effects underpinned by common mechanisms. Genes Nutr. 2009;4(4):243\u201350.","journal-title":"Genes Nutr"},{"key":"364_CR27","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.freeradbiomed.2008.04.008","volume":"45","author":"CM Williams","year":"2008","unstructured":"Williams CM, Mohsen MA, Vauzour D, Rendeiro C, Butler LT, Ellis JA, et al. Blueberry-induced changes in spatial working memory correlate with changes in hippocampal CREB phosphorylation and brain-derived neurotrophic factor (BDNF) levels. Free Radic Biol Med. 2008;45:295\u2013305.","journal-title":"Free Radic Biol Med"},{"key":"364_CR28","doi-asserted-by":"crossref","unstructured":"Elumalai P, Lakshmi S. Role of Quercetin benefits in neurodegeneration. Adv Neurobiol. 2016;12:229\u2013245.","DOI":"10.1007\/978-3-319-28383-8_12"},{"key":"364_CR29","doi-asserted-by":"publisher","first-page":"30","DOI":"10.2174\/1871524911313010005","volume":"13","author":"F Dajas","year":"2013","unstructured":"Dajas F, Andr\u00e9s AC, Florencia A, Carolina E, Felicia RM. Neuroprotective actions of flavones and flavonols: mechanisms and relationship to flavonoid structural features. Cent Nerv Syst Agents Med Chem. 2013;13:30\u20135.","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"364_CR30","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1111\/1750-3841.14317","volume":"83","author":"F Babaei","year":"2018","unstructured":"Babaei F, Mirzababaei M, Nassiri-Asl M. Quercetin in food: possible mechanisms of its effect on memory. J Food Sci. 2018;83:2280\u20137.","journal-title":"J Food Sci"},{"key":"364_CR31","doi-asserted-by":"publisher","first-page":"e0219075","DOI":"10.1371\/journal.pone.0219075","volume":"14","author":"A Tripathi","year":"2019","unstructured":"Tripathi A, Kumar B, Sagi SSK. Prophylactic efficacy of Quercetin in ameliorating the hypoxia induced vascular leakage in lungs of rats. PLoS\u00a0One. 2019;14:e0219075.","journal-title":"PLoS\u00a0One"},{"key":"364_CR32","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/hr.2015.16","volume":"38","author":"R Tiradentes","year":"2015","unstructured":"Tiradentes R, Santuzzi C, Claudio E, Mengal V, Silva N, Neto H, et al. Combined aliskiren and L-arginine treatment reverses renovascular hypertension in an animal model. Hypertens Res. 2015;38:471\u20137.","journal-title":"Hypertens Res"},{"key":"364_CR33","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.physbeh.2015.09.007","volume":"152","author":"S Jain","year":"2015","unstructured":"Jain S, Sharma B. Neuroprotective effect of selective DPP-4 inhibitor in experimental vascular dementia. Physiol Behav. 2015;152:182\u201393.","journal-title":"Physiol Behav"},{"key":"364_CR34","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.brainres.2016.04.022","volume":"1642","author":"S Jayant","year":"2016","unstructured":"Jayant S, Sharma BM, Sharma B. Protective effect of transient receptor potential vanilloid subtype 1 (TRPV1) modulator, against behavioral, biochemical and structural damage in experimental models of Alzheimer\u2019s disease. Brain Res. 2016;1642:397\u2013408.","journal-title":"Brain Res"},{"key":"364_CR35","doi-asserted-by":"publisher","first-page":"147116","DOI":"10.1016\/j.brainres.2020.147116","volume":"1748","author":"P Sharma","year":"2020","unstructured":"Sharma P, Kulkarni GT, Sharma B. Possible involvement of D2\/D3 receptor activation in ischemic preconditioning mediated protection of the brain. Brain Res. 2020;1748:147116.","journal-title":"Brain Res"},{"key":"364_CR36","first-page":"H2103","volume":"264","author":"G Simone","year":"1993","unstructured":"Simone G, Devereux RB, Camargo MJ, Wallerson DC, Laragh JH. Influence of sodium intake on in vivo left ventricular anatomy in experimental renovascular hypertension. Am J Physiol. 1993;264:H2103\u201310.","journal-title":"Am J Physiol"},{"key":"364_CR37","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1097\/00005344-199406001-00007","volume":"23","author":"A Corbier","year":"1994","unstructured":"Corbier A, Lecaque D, Secchi J, Depouez B, Ramon G. Effect of 4 weeks of treatment with trandolapril on renal hypertension and cardiac and vascular hypertrophy in the rat. J Cardiovasc Pharmacol Ther. 1994;23:S26\u20139.","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"1","key":"364_CR38","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40885-016-0055-8","volume":"22","author":"YH Zhang","year":"2016","unstructured":"Zhang YH. Neuronal nitric oxide synthase in hypertension \u2013 an update. Clin Hypertens. 2016;22(1):20.","journal-title":"Clin Hypertens"},{"issue":"2","key":"364_CR39","doi-asserted-by":"publisher","first-page":"94","DOI":"10.2174\/1567202611666140305221854","volume":"11","author":"S Gupta","year":"2014","unstructured":"Gupta S, Sharma B, Singh P, Sharma BM. Modulation of transient receptor potential vanilloid subtype 1 (TRPV1) and norepinephrine transporters (NET) protect against oxidative stress, cellular injury, and vascular dementia. Curr Neurovasc Res. 2014;11(2):94\u2013106.","journal-title":"Curr Neurovasc Res"},{"issue":"1","key":"364_CR40","doi-asserted-by":"publisher","first-page":"10","DOI":"10.2174\/1567202612666151026105610","volume":"13","author":"P Singh","year":"2016","unstructured":"Singh P, Sharma B. Reversal in cognition impairments, cholinergic dysfunction, and cerebral oxidative stress through the modulation of ryanodine receptors (RyRs) and cysteinyl leukotriene-1 (CysLT1) receptors. Curr Neurovasc Res. 2016;13(1):10\u201321.","journal-title":"Curr Neurovasc Res"},{"issue":"3","key":"364_CR41","doi-asserted-by":"publisher","first-page":"202","DOI":"10.5958\/2231-5713.2020.00033.1","volume":"10","author":"S Derouiche","year":"2020","unstructured":"Derouiche S, Cheradid T, Guessoum M. Heavy metals. Oxidative stress and inflammation in pathophysiology of chronic kidney disease: a review. AJPTech. 2020;10(3):202\u20136.","journal-title":"AJPTech"},{"issue":"2","key":"364_CR42","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1161\/HYPERTENSIONAHA.108.127928","volume":"54","author":"JD Widder","year":"2009","unstructured":"Widder JD, Fraccarollo D, Galuppo P, Hansen JM, Jones DP, Ertl G, et al. Attenuation of angiotensin II-induced vascular dysfunction and hypertension by overexpression of Thioredoxin 2. Hypertension. 2009;54(2):338\u201344.","journal-title":"Hypertension"},{"issue":"4","key":"364_CR43","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1161\/CIRCRESAHA.107.162800","volume":"102","author":"AK Doughan","year":"2008","unstructured":"Doughan AK, Harrison DG, Dikalov SI. Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction. Circ Res. 2008;102(4):488\u201396.","journal-title":"Circ Res"},{"key":"364_CR44","doi-asserted-by":"crossref","unstructured":"Miguel D, Rudemiller NP, Abais JM, Mattson DL. Inflammation and hypertension: new understandings and potential therapeutic targets. Curr Hypertens Rep. 2015;17(1):507.","DOI":"10.1007\/s11906-014-0507-z"},{"issue":"3","key":"364_CR45","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00011-015-0907-9","volume":"65","author":"J Chen","year":"2016","unstructured":"Chen J, Wang J, Su C, Qian W, Sun L, Sun H. Urinary trypsin inhibitor attenuates LPS-induced endothelial barrier dysfunction by upregulation of vascular endothelial-cadherin expression. Inflamm Res. 2016;65(3):213\u201324.","journal-title":"Inflamm Res"},{"key":"364_CR46","doi-asserted-by":"publisher","first-page":"5790","DOI":"10.1038\/s41598-019-42286-8","volume":"9","author":"JS Zhao","year":"2019","unstructured":"Zhao JS, Bi W, Xiao S, et al. Neuroinflammation induced by lipopolysaccharide causes cognitive impairment in mice. Sci Rep. 2019;9:5790.","journal-title":"Sci Rep"},{"issue":"2","key":"364_CR47","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0021-5198(19)32430-8","volume":"60","author":"T Shikimi","year":"1992","unstructured":"Shikimi T, Hattori K, Takaori S. Existence of a human urinary trypsin inhibitor (urinastatin)-like substance in the rat brain. Jpn J Pharmacol. 1992;60(2):97\u2013103.","journal-title":"Jpn J Pharmacol"},{"issue":"4","key":"364_CR48","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.bbrc.2015.01.155","volume":"458","author":"L Yuting","year":"2015","unstructured":"Yuting L, Zhao L, Fu H, Wu Y, Wang T. Ulinastatin suppresses lipopolysaccharide induced neuro-inflammation through the downregulation of nuclear factor-\u03baB in SD rat hippocampal astrocyte. Biochem Biophys Res Commun. 2015;458(4):763\u201370.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"364_CR49","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1159\/000430279","volume":"36","author":"W Guo","year":"2015","unstructured":"Guo W, Zhihong L, Xie X, Qin T, Wu Y, Li Z. Urinary trypsin inhibitor attenuates acute lung injury by improving endothelial progenitor cells functions. Cell Physiol Biochem. 2015;36(3):1059\u201368.","journal-title":"Cell Physiol Biochem"},{"issue":"11","key":"364_CR50","first-page":"7342","volume":"7","author":"G Li","year":"2014","unstructured":"Li G, Li T, Li Y, Cai S, Zhang Z, Zeng Z, et al. Ulinastatin inhibits oxidant-induced endothelial hyperpermeability and apoptotic signaling. Int J Clin Exp Pathol. 2014;7(11):7342\u201350.","journal-title":"Int J Clin Exp Pathol"},{"key":"364_CR51","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0021-5198(19)32414-X","volume":"60","author":"Y Kudo","year":"1990","unstructured":"Kudo Y, Egashira T, Yamanaka Y. Protective effect of ulinastatin against liver injury caused by ischemia\u2013reperfusion in rats. Jpn J Pharmaol. 1990;60:239\u201345.","journal-title":"Jpn J Pharmaol"},{"key":"364_CR52","doi-asserted-by":"crossref","unstructured":"Liu B, Huang W, Xiao X, Xu Y, Ma S, Xia Z. Neuroprotective effect of ulinastatin on spinal cord ischemia\u2013reperfusion injury in rabbits. Oxid Med Cell Longev 2015;1\u20138.","DOI":"10.1155\/2015\/624819"},{"issue":"3","key":"364_CR53","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s10753-018-0734-6","volume":"41","author":"F Song","year":"2018","unstructured":"Song F, Kong F, Zhang H, Zhou Y, Li M. Ulinastatin protects against CVB3-induced acute viral myocarditis through Nrf2 activation. Inflammation. 2018;41(3):803\u201310.","journal-title":"Inflammation"},{"issue":"24","key":"364_CR54","first-page":"8990","volume":"22","author":"S Wang","year":"2018","unstructured":"Wang S, Cheng ZY, Chen XJ, Xue HZ. Ulinastatin protects rats with myocardial infarction by activating Nrf2\/NOS pathway. Eur Rev Med Pharmacol Sci. 2018;22(24):8990\u20138.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"364_CR55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/01616412.2016.1251695","volume":"39","author":"L Xiaofang","year":"2017","unstructured":"Xiaofang L, Likai S, Xiangjian Z, Zhang C, Lina W, Yaoru L, et al. Ulinastatin downregulates TLR4 and NF-kB expression and protects mouse brains against ischemia\/reperfusion injury. Neurol Res. 2017;39:1\u20137.","journal-title":"Neurol Res"},{"key":"364_CR56","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/ptr.2008","volume":"21","author":"MR Loizzo","year":"2007","unstructured":"Loizzo MR, Said A, Tundis R, Rashed K, Statti GA, Hufner A, et al. Inhibition of angiotensin converting enzyme (ACE) by flavonoids isolated from Ailanthus excelsa (Roxb) (Simaroubaceae). Phytother Res. 2007;21:32\u20136.","journal-title":"Phytother Res"},{"issue":"1","key":"364_CR57","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3390\/ph3010237","volume":"3","author":"A Larson","year":"2010","unstructured":"Larson A, Symons JD, Jalili T. Quercetin: a treatment for hypertension?\u2014A review of efficacy and mechanisms. Pharmaceuticals. 2010;3(1):237\u201350.","journal-title":"Pharmaceuticals"},{"issue":"11","key":"364_CR58","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1093\/jn\/137.11.2405","volume":"137","author":"RL Edwards","year":"2007","unstructured":"Edwards RL, Lyon T, Litwin SE, Rabovsky A, Symons JD, Jalili T. Quercetin reduces blood pressure in hypertensive subjects. J Nutr. 2007;137(11):2405\u201311.","journal-title":"J Nutr"},{"issue":"1","key":"364_CR59","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/01.hjh.0000198029.22472.d9","volume":"24","author":"M S\u00e1nchez","year":"2006","unstructured":"S\u00e1nchez M, Galisteo M, Vera R, Villar IC, Zarzuelo A, Tamargo J, et al. Quercetin downregulates NADPH oxidase, increases eNOS activity and prevents endothelial dysfunction in spontaneously hypertensive rats. J Hypertens. 2006;24(1):75\u201384.","journal-title":"J Hypertens"},{"issue":"5","key":"364_CR60","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.freeradbiomed.2010.05.020","volume":"49","author":"F Arredondo","year":"2010","unstructured":"Arredondo F, Echeverry C, Carriquiry JAA, Blasina F, Antunez K, Jones D, et al. After cellular internalization, quercetin causes Nrf2 nuclear translocation, increases glutathione levels, and prevents neuronal death against an oxidative insult. Free Radic Biol Med. 2010;49(5):738\u201347.","journal-title":"Free Radic Biol Med"},{"key":"364_CR61","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.3389\/fphar.2018.01383","volume":"9","author":"A Khan","year":"2018","unstructured":"Khan A, Ali T, Rehman S, Khan S, Alam I, Ikram M, et al. Neuroprotective effect of quercetin against the detrimental effects of LPS in the adult mouse brain. Front Pharmacol. 2018;9:1383.","journal-title":"Front Pharmacol"},{"key":"364_CR62","first-page":"CD001190","volume":"1","author":"JS Birks","year":"2006","unstructured":"Birks JS, Harvey RJ. Donepezil for dementia due to Alzheimer\u2019s disease. Cochrane Database Syst Rev. 2006;1:CD001190.","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-022-00364-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-022-00364-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-022-00364-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T21:02:48Z","timestamp":1668286968000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-022-00364-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,9]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["364"],"URL":"https:\/\/doi.org\/10.1007\/s43440-022-00364-1","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,9]]},"assertion":[{"value":"17 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors (Poonam Sharma, Nikita Gaur, Shalini Jayant, B.M. Sharma, Bhagwat Singh, Harsha Kharkwal, Bhupesh Sharma) who have contributed to this manuscript directly have agreed towards submitting and publishing this article to this journal. The authors have no financial or non-financial conflict of interest either directly or indirectly. They received no grants for the research conducted neither they received any receipt of consulting fee from any company for their research. Further, the authors declare that they have no social or personal activities\/interests that may cause biasness in how they conducted this research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All the unprocessed raw data of this study have been incorporated in a supplementary file.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}}]}}